Postoperative atrial fibrillation (POAF) is a common, expensive and potentially morbid
complication following cardiac surgery. POAF occurs in around 35% of cardiac surgery …

ContextAlthough amiodarone is approved by the US Food and Drug Administration only for
refractory ventricular arrhythmias, it is one of the most frequently prescribed antiarrhythmic …

Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

Rationale: Patients admitted to intensive care units with sepsis are prone to developing
cardiac dysrhythmias, most commonly atrial fibrillation. Objectives: To determine the …

Aims Atrial fibrillation (AF) is the most common complication after cardiac surgery. We aimed
to evaluate, by meta-analysis, all randomized trials testing interventions for preventing AF …

Arrhythmias are a known complication after cardiac surgery and represent a major cause of
morbidity, increased length of hospital stay, and economic costs. However, little is known …

Although amiodarone is considered the most effective antiarrhythmic agent, its use is limited
by a wide variety of potential toxicities. The purpose of this review is to provide a …

Atrial fibrillation (AF) is a commonly encountered arrhythmia in clinical practice, and is a
wellrecognized complication of cardiac surgery. The occurrence of postoperative AF (POAF) …

Amiodarone is an antiarrhythmic agent commonly used to treat supraventricular and
ventricular arrhythmias. This drug is an iodinecontaining compound that tends to accumulate …

Amiodarone is commonly used to treat supraventricular and ventricular arrhythmias in
various inpatient and outpatient settings. Over-and under-use of amiodarone is common …